Sensus Healthcare, Inc. (SRTS)
USD 4.45
(-9.29%)
USD 4.45
(-9.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 485 Thousand USD | -98.0% |
| 2022 | 24.24 Million USD | 488.59% |
| 2021 | 4.11 Million USD | 187.35% |
| 2020 | -4.71 Million USD | -308.5% |
| 2019 | -1.15 Million USD | 42.94% |
| 2018 | -2.02 Million USD | 45.49% |
| 2017 | -3.71 Million USD | -971.02% |
| 2016 | -346.44 Thousand USD | -46.02% |
| 2015 | -237.26 Thousand USD | 93.59% |
| 2014 | -3.69 Million USD | -3537.31% |
| 2013 | 107.62 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.61 Million USD | -29.11% |
| 2024 Q1 | 2.27 Million USD | -45.99% |
| 2023 Q4 | 4.21 Million USD | 390.14% |
| 2023 Q1 | -1.89 Million USD | -166.95% |
| 2023 Q2 | -380 Thousand USD | 79.94% |
| 2023 Q3 | -1.45 Million USD | -281.84% |
| 2023 FY | 485 Thousand USD | -98.0% |
| 2022 Q3 | 1.82 Million USD | -48.1% |
| 2022 Q4 | 2.82 Million USD | 54.67% |
| 2022 FY | 24.24 Million USD | 488.59% |
| 2022 Q1 | 16.06 Million USD | 202.03% |
| 2022 Q2 | 3.52 Million USD | -78.06% |
| 2021 Q4 | 5.31 Million USD | 2627.18% |
| 2021 Q3 | 195 Thousand USD | 169.89% |
| 2021 Q2 | -279 Thousand USD | 74.98% |
| 2021 FY | 4.11 Million USD | 187.35% |
| 2021 Q1 | -1.11 Million USD | -209.48% |
| 2020 Q2 | -2.57 Million USD | 28.23% |
| 2020 FY | -4.71 Million USD | -308.5% |
| 2020 Q4 | 1.01 Million USD | 160.18% |
| 2020 Q3 | -1.69 Million USD | 34.27% |
| 2020 Q1 | -3.58 Million USD | -445.21% |
| 2019 Q4 | 1.03 Million USD | 242.27% |
| 2019 FY | -1.15 Million USD | 42.94% |
| 2019 Q2 | 112.3 Thousand USD | 105.3% |
| 2019 Q3 | -730.39 Thousand USD | -750.35% |
| 2019 Q1 | -2.12 Million USD | -2181.25% |
| 2018 Q4 | 101.91 Thousand USD | 122.25% |
| 2018 FY | -2.02 Million USD | 45.49% |
| 2018 Q1 | -1.12 Million USD | -175.57% |
| 2018 Q2 | -540.65 Thousand USD | 51.98% |
| 2018 Q3 | -458.1 Thousand USD | 15.27% |
| 2017 Q3 | -965.68 Thousand USD | -26.38% |
| 2017 Q2 | -764.11 Thousand USD | 51.4% |
| 2017 Q1 | -1.57 Million USD | -4837.62% |
| 2017 Q4 | -408.58 Thousand USD | 57.69% |
| 2017 FY | -3.71 Million USD | -971.02% |
| 2016 Q1 | 2081.00 USD | -99.5% |
| 2016 Q2 | -351.29 Thousand USD | -16981.26% |
| 2016 Q3 | -30.41 Thousand USD | 91.34% |
| 2016 FY | -346.44 Thousand USD | -46.02% |
| 2016 Q4 | 33.18 Thousand USD | 209.11% |
| 2015 Q3 | -78.07 Thousand USD | 12.03% |
| 2015 Q1 | -485.26 Thousand USD | 0.0% |
| 2015 FY | -237.26 Thousand USD | 93.59% |
| 2015 Q4 | 414.81 Thousand USD | 631.32% |
| 2015 Q2 | -88.74 Thousand USD | 81.71% |
| 2014 FY | -3.69 Million USD | -3537.31% |
| 2013 FY | 107.62 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 100.787% |
| BrainsWay Ltd. | -4.19 Million USD | 111.556% |
| Cerus Corporation | -37.48 Million USD | 101.294% |
| Envoy Medical, Inc. | -29.9 Million USD | 101.622% |
| electroCore, Inc. | -18.83 Million USD | 102.575% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 105.48% |
| IceCure Medical Ltd | -14.65 Million USD | 103.31% |
| Inogen, Inc. | -102.44 Million USD | 100.473% |
| OrthoPediatrics Corp. | -20.97 Million USD | 102.312% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 100.921% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 103.529% |
| MaxCyte, Inc. | -37.92 Million USD | 101.279% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 104.09% |
| Nexalin Technology, Inc. | -4.64 Million USD | 110.433% |
| Orthofix Medical Inc. | -151.39 Million USD | 100.32% |
| PAVmed Inc | -64.17 Million USD | 100.756% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 100.924% |
| RxSight, Inc. | -48.6 Million USD | 100.998% |
| Sight Sciences, Inc. | -55.54 Million USD | 100.873% |
| SI-BONE, Inc. | -43.33 Million USD | 101.119% |
| TELA Bio, Inc. | -46.66 Million USD | 101.039% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 100.979% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 103.571% |
| Acutus Medical, Inc. | -81.66 Million USD | 100.594% |
| Talis Biomedical Corporation | -62 Million USD | 100.782% |
| Spectral AI, Inc. | -20.85 Million USD | 102.326% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 100.798% |
| CVRx, Inc. | -41.19 Million USD | 101.177% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 24.242% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 104.427% |
| Bioventus Inc. | -156.23 Million USD | 100.31% |
| Venus Concept Inc. | -37.25 Million USD | 101.302% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 100.822% |
| LivaNova PLC | 17.54 Million USD | 97.236% |
| 908 Devices Inc. | -36.39 Million USD | 101.332% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 100.26% |
| Nemaura Medical Inc. | -14.14 Million USD | 103.429% |
| NeuroPace, Inc. | -32.95 Million USD | 101.472% |
| LENSAR, Inc. | -14.38 Million USD | 103.372% |
| Apyx Medical Corporation | -18.71 Million USD | 102.592% |
| Cutera, Inc. | -162.83 Million USD | 100.298% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 104.478% |
| BioSig Technologies, Inc. | -29.04 Million USD | 101.67% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 100.587% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 102.196% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 99.284% |
| Axonics, Inc. | -6.08 Million USD | 107.966% |
| Outset Medical, Inc. | -172.79 Million USD | 100.281% |
| IRIDEX Corporation | -9.57 Million USD | 105.068% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 100.458% |
| IRadimed Corporation | 17.19 Million USD | 97.179% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 105.883% |
| INVO Bioscience, Inc. | -8.03 Million USD | 106.036% |
| Telesis Bio, Inc. | -47.72 Million USD | 101.016% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 95.265% |
| Varex Imaging Corporation | -47.7 Million USD | 101.017% |
| Quipt Home Medical Corp. | -2.78 Million USD | 117.421% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 104.297% |
| Pulmonx Corporation | -60.84 Million USD | 100.797% |
| Dynatronics Corporation | -2.69 Million USD | 117.978% |
| Modular Medical, Inc. | -17.47 Million USD | 102.776% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 104.259% |
| Semler Scientific, Inc. | 20.58 Million USD | 97.644% |
| InMode Ltd. | 197.91 Million USD | 99.755% |
| Bruker Corporation | 427.2 Million USD | 99.886% |
| Cytosorbents Corporation | -28.5 Million USD | 101.701% |
| DexCom, Inc. | 541.5 Million USD | 99.91% |
| Align Technology, Inc. | 445.05 Million USD | 99.891% |
| Viveve Medical, Inc. | -22.02 Million USD | 102.202% |
| ZimVie Inc. | -393.28 Million USD | 100.123% |
| Movano Inc. | -29.28 Million USD | 101.656% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 103.992% |
| Nexalin Technology, Inc. | -4.64 Million USD | 110.433% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 24.242% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 100.218% |
| Profound Medical Corp. | -28.56 Million USD | 101.698% |
| Insulet Corporation | 206.3 Million USD | 99.765% |
| enVVeno Medical Corporation | -23.51 Million USD | 102.062% |
| Surmodics, Inc. | -11.54 Million USD | 104.202% |
| iCAD, Inc. | -4.84 Million USD | 110.006% |
| Nuwellis, Inc. | -20.2 Million USD | 102.4% |
| Biotricity, Inc. | -14.09 Million USD | 103.441% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 100.393% |
| Aethlon Medical, Inc. | -12.2 Million USD | 103.973% |
| InspireMD, Inc. | -19.91 Million USD | 102.435% |
| PAVmed Inc. | -64.17 Million USD | 100.756% |
| BIOLASE, Inc. | -20.63 Million USD | 102.351% |
| Beyond Air, Inc. | -60.24 Million USD | 100.805% |
| FONAR Corporation | 10.56 Million USD | 95.41% |
| AxoGen, Inc. | -21.71 Million USD | 102.233% |
| Vivani Medical, Inc. | -25.65 Million USD | 101.891% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 98.299% |
| Inari Medical, Inc. | -1.63 Million USD | 129.645% |
| UFP Technologies, Inc. | 44.92 Million USD | 98.92% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 109.45% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 107.343% |
| Tenon Medical, Inc. | -15.58 Million USD | 103.113% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 103.144% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 101.373% |
| AdaptHealth Corp. | -678.89 Million USD | 100.071% |
| Sintx Technologies, Inc. | -8.25 Million USD | 105.872% |
| NanoVibronix, Inc. | -3.71 Million USD | 113.069% |
| Quanterix Corporation | -32.33 Million USD | 101.5% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 104.297% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 100.158% |
| TransMedics Group, Inc. | -25.02 Million USD | 101.938% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 102.191% |
| NeuroMetrix, Inc. | -6.52 Million USD | 107.428% |
| Hyperfine, Inc. | -44.23 Million USD | 101.096% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 100.618% |
| Biomerica, Inc. | -5.97 Million USD | 108.113% |
| Bone Biologics Corporation | -8.94 Million USD | 105.42% |
| AVITA Medical, Inc. | -39.16 Million USD | 101.238% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 104.872% |
| Silk Road Medical, Inc | -55.74 Million USD | 100.87% |